The published commentary connects care practice, fair access, the cost of late-stage disease and the question of how prevention can be financed fairly.

Care delivery perspective

Glaucoma can remain unnoticed for a long time. This makes early detection a question of access, care pathways and timely diagnosis.

A robust assessment must consider medical benefit, organizational feasibility and financing together.

Health-economic perspective

Late-stage disease can have considerable consequences for affected people and the care system. Prevention should therefore be considered in relation to burdens that may be avoided.

The article is a personal professional position and not medical advice for individual cases.

Sources

  • OPHTHALMO-CHIRURGIE, 38th year, issue 2, March 2026, pages 73–74.